Hormone replacement therapy and the adolescent

Current Opinion in Obstetrics and Gynecology

Volumn 22, Issue 5, 2010, Pages 363-368

  Divasta, Amy D ^a,b   Gordon, Catherine M ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Division of Pediatric and Adolescent Gynecology   (United States)

Author keywords

adolescence; estrogen deficiency; hormone replacement

Indexed keywords

CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; ESTRONE SULFATE; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS ETONOGESTREL; MEDROXYPROGESTERONE ACETATE; ORTHOEVA; PROGESTERONE; SEX HORMONE; UNCLASSIFIED DRUG;

ADD ON THERAPY; BONE DENSITY; BREAST DEVELOPMENT; CHILD HEALTH CARE; CLINICAL TRIAL; DEPRESSION; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG METABOLISM; ESTROGEN BLOOD LEVEL; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; LOW DRUG DOSE; MAINTENANCE THERAPY; MENSTRUATION; MENTAL INSTABILITY; OVARY INSUFFICIENCY; PRIORITY JOURNAL; PUBERTY; REVIEW; SECONDARY AMENORRHEA; SLEEP DISORDER; TREATMENT INDICATION; TURNER SYNDROME;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADOLESCENT; AMENORRHEA; CALCIFICATION, PHYSIOLOGIC; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; OVARIAN DISEASES;

EID: 77956450003     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e32833e4a35     Document Type: Review

References (36)

1. Bondy CA. Care of girls and women with turner syndrome: a guideline of the turner syndrome study group. J Clin Endocrinol Metab 2007; 92:10-25.
2. Bannink EM, Raat H, Mulder PG, de Muinck Keizer-Schrama SM. Quality of life after growth hormone therapy and induced puberty in women with Turner syndrome. J Pediatr 2006; 148:95-101.
3. Bannink EM, van Sassen C, van Buuren S, et al. Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels. Clin Endocrinol (Oxf) 2009; 70:265-273.
4. Suganuma N, Furuhashi M, Hirooka T, et al. Bone mineral density in adult patients with Turner's syndrome: analyses of the effectiveness of GH and ovarian steroid hormone replacement therapies. Endocr J 2003; 50:263-269.
5. Ankarberg-Lindgren C, Elfving M, Wikland KA, Norjavaara E. Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls. J Clin Endocrinol Metab 2001; 86:3039-3044.
6. Davenport ML. Approach to the patient with Turner syndrome. J Clin Endocrinol Metab Apr; 95:1487-1495.
7. Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009; 360:606-614.
8. Ostberg JE, Storry C, Donald AE, et al. A dose-response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism. Clin Endocrinol (Oxf) 2007; 66:557-564.
9. Kalantaridou SN, Naka KK, Papanikolaou E, et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab 2004; 89:3907-3913.
10. Lieberman S. Are the differences between estradiol and other estrogens, naturally occurring or synthetic, merely semantical? J Clin Endocrinol Metab 1996; 81:850-851.
11. Rosenfield RL, Perovic N, Devine N, et al. Optimizing estrogen replacement treatment in Turner syndrome. Pediatrics 1998; 102 (2 Pt 3):486-488.
12. Lissett CA, Shalet SM. The impact of dose and route of estrogen administration on the somatotropic axis in normal women. J Clin Endocrinol Metab 2003; 88:4668-4672.
13. Mah PM, Webster J, Jonsson P, et al. Estrogen replacement in women of fertile years with hypopituitarism. J Clin Endocrinol Metab 2005; 90:5964-5969.
14. O'sullivan AJ, Crampton LJ, Freund J, Ho KK. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women. J Clin Invest 1998; 102:1035-1040.
15. Scarabin PY, Oger E, Plu-Bureau G. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 2003; 362:428-432.
16. Canonico M, Oger E, Plu-Bureau G, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 2007; 115:840-845.
17. Zegura B, Keber I, Sebestjen M, Koenig W. Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis. Atherosclerosis 2003; 168:123-129. (Pubitemid 36555819)
18. Peter F. Sex steroid replacement during and after the induction of puberty. Growth Horm IGF Res 2003; 13 (Suppl A):S136-S142.
19. Paterson WF, Hollman AS, Donaldson MD. Poor uterine development in Turner syndrome with oral oestrogen therapy. Clin Endocrinol (Oxf) 2002; 56:359-365.
20. Illig R, DeCampo C, Lang-Muritano MR, et al. A physiological mode of puberty induction in hypogonadal girls by low dose transdermal 17 beta-oestradiol. Eur J Pediatr 1990; 150:86-91.
21. Nabhan ZM, Dimeglio LA, Qi R, et al. Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study. J Clin Endocrinol Metab 2009; 94:2009-2014.
22. Mauras N, Shulman D, Hsiang HY, et al. Metabolic effects of oral versus transdermal estrogen in growth hormone-treated girls with turner syndrome. J Clin Endocrinol Metab 2007; 92:4154-4160.
23. Piippo S, Lenko H, Kainulainen P, Sipila I. Use of percutaneous estrogen gel for induction of puberty in girls with Turner syndrome. J Clin Endocrinol Metab 2004; 89:3241-3247.
24. Warren MP, Biller BM, Shangold MM. A new clinical option for hormone replacement therapy in women with secondary amenorrhea: effects of cyclic administration of progesterone from the sustained-release vaginal gel Crinone (4% and 8%) on endometrial morphologic features and withdrawal bleeding. Am J Obstet Gynecol 1999; 180 (1 Pt 1):42-48.
25. Liu SL, Lebrun CM. Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and perimenopausal women: a systematic review. Br J Sports Med 2006; 40:11-24.
26. Gordon CM, Grace E, Emans SJ, et al. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab 2002; 87:4935-4941.
27. Klibanski A, Biller BM, Schoenfeld DA, et al. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 1995; 80:898-904.
28. Grinspoon S, Thomas L, Miller K, et al. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 2002; 87:2883-2891.
29. Golden NH. Eating disorders in adolescence: what is the role of hormone replacement therapy? Curr Opin Obstet Gynecol 2007; 19:434-439.
30. Uygur D, Sengul O, Bayar D, et al. Bone loss in young women with premature ovarian failure. Arch Gynecol Obstet 2005; 273:17-19.
31. Bachrach LK, Guido D, Katzman D, et al. Decreased bone density in adolescent girls with anorexia nervosa. Pediatrics 1990; 86:440-447.
32. Golden NH. Osteopenia and osteoporosis in anorexia nervosa. Adolesc Med 2003; 14:97-108.
33. Cromer BA, Stager M, Bonny A, et al. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health 2004; 35:434-441. (Pubitemid 39576013)
34. Polatti F, Perotti F, Filippa N, et al. Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception 1995; 51:221-224.
35. Scholes D, Ichikawa L, LaCroix AZ, et al. Oral contraceptive use and bone density in adolescent and young adult women. Contraception 2010; 81:35-40.
36. Massaro M, Di Carlo C, Gargano V, et al. Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study. Contraception 2010; 81:209-214.